FDA Grants Priority Review To Genentech’s Application for Enspryng, the First and Only At-Home Subcutaneous Treatment Option for Thyroid Eye Disease (TED)
Go back to FDA Grants Priority Review To Genentech’s Application for Enspryng, the First and Only At-Home Subcutaneous Treatment Option for Thyroid Eye Disease (TED)| Roche Holding AG Basel American Depositary Shares (AMEX: RHHBY) | Delayed: 51.70 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $51.70 | 52 Week High | $35.13 | |||
| Open | $51.70 | 52 Week Low | $28.10 | |||
| Day High | $51.70 | P/E | N/A | |||
| Day Low | $51.70 | EPS | $0.00 | |||
| Volume | 174 | |||||
| Brown & Brown, Inc. (NYSE: RO) | Delayed: 8.49 +0.55 (6.93%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $7.94 | 52 Week High | $8.59 | |||
| Open | $7.94 | 52 Week Low | $7.82 | |||
| Day High | $8.59 | P/E | 6.53 | |||
| Day Low | $7.82 | EPS | $1.30 | |||
| Volume | 42,732 | |||||
| Roper Industries (NASDAQ: ROP) | Delayed: 336.71 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $336.71 | 52 Week High | $195.93 | |||
| Open | $336.71 | 52 Week Low | $155.79 | |||
| Day High | $336.71 | P/E | 62.70 | |||
| Day Low | $336.71 | EPS | $5.37 | |||
| Volume | 16,871 | |||||
